AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals (2025) Faisal S. Ali

Description

This clinical practice guideline provides evidence-based recommendations for frontline health care practitioners regarding the management of Hepatitis B Virus reactivation (HBVr) in at-risk individuals. It assesses the role of antiviral prophylaxis versus clinical monitoring for mitigating HBVr risk following various immune-modulating exposures and disease states.